全文获取类型
收费全文 | 112013篇 |
免费 | 48265篇 |
国内免费 | 2693篇 |
专业分类
耳鼻咽喉 | 1774篇 |
儿科学 | 4714篇 |
妇产科学 | 995篇 |
基础医学 | 19903篇 |
口腔科学 | 5968篇 |
临床医学 | 17334篇 |
内科学 | 28398篇 |
皮肤病学 | 7836篇 |
神经病学 | 14873篇 |
特种医学 | 3589篇 |
外国民族医学 | 17篇 |
外科学 | 17714篇 |
综合类 | 6917篇 |
现状与发展 | 12篇 |
一般理论 | 38篇 |
预防医学 | 6890篇 |
眼科学 | 2583篇 |
药学 | 9371篇 |
57篇 | |
中国医学 | 3384篇 |
肿瘤学 | 10604篇 |
出版年
2024年 | 140篇 |
2023年 | 720篇 |
2022年 | 1799篇 |
2021年 | 3577篇 |
2020年 | 6690篇 |
2019年 | 12143篇 |
2018年 | 11450篇 |
2017年 | 12704篇 |
2016年 | 13250篇 |
2015年 | 13702篇 |
2014年 | 14080篇 |
2013年 | 14361篇 |
2012年 | 7108篇 |
2011年 | 7299篇 |
2010年 | 10976篇 |
2009年 | 7000篇 |
2008年 | 4161篇 |
2007年 | 2928篇 |
2006年 | 3011篇 |
2005年 | 2473篇 |
2004年 | 1970篇 |
2003年 | 1804篇 |
2002年 | 1697篇 |
2001年 | 1594篇 |
2000年 | 1461篇 |
1999年 | 1057篇 |
1998年 | 549篇 |
1997年 | 493篇 |
1996年 | 386篇 |
1995年 | 338篇 |
1994年 | 340篇 |
1993年 | 196篇 |
1992年 | 249篇 |
1991年 | 199篇 |
1990年 | 167篇 |
1989年 | 204篇 |
1988年 | 139篇 |
1987年 | 139篇 |
1986年 | 68篇 |
1985年 | 72篇 |
1984年 | 49篇 |
1983年 | 33篇 |
1982年 | 29篇 |
1981年 | 30篇 |
1980年 | 26篇 |
1979年 | 31篇 |
1978年 | 14篇 |
1977年 | 7篇 |
1975年 | 11篇 |
1974年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
101.
102.
Jim Zhong Michael Gallagher Chris Hounslow Gareth Iball Tze Wah 《Diagnostic and interventional radiology (Ankara, Turkey)》2021,27(2):244
PURPOSEWe aimed to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in computed tomography (CT)-guided percutaneous cryoablation.METHODSWe conducted a retrospective study of 103 patients undergoing cryoablation in a tertiary cancer center. Overall, 62 patients were scanned with standard exposure parameters (full dose group) set on a 64-slice multidetector CT scanner, while 41 patients were scanned on a reduced dose protocol. Dose levels were retrieved from the hospital picture and archiving communication system including the volumetric CT dose index (CTDIvol), total dose length product (DLP), length of cryoablation procedure, number of cryoablation needles and patient size. Wilcoxon Mann-Whitney (rank-sum) tests were used to compare the median DLP, CTDIvol and skin dose between the two groups.RESULTSMedian total DLP for the full dose group was 6025 mGy·cm (1909–13353 mGy·cm) compared with 3391 mGy·cm (1683–6820 mGy·cm) for the reduced dose group. The reduced dose group had a 44% reduction in total DLP and 42% reduction in total CTDIvol (p < 0.001). The estimated skin doses were 384 mGy for the full dose group and 224 mGy for the reduced dose group (42% reduction) (p < 0.001). At 12-month follow-up, the technical success for the full dose (n=62) was 97% with 2 patients requiring a further cryoablation treatment for residual tumor. The technical success for the reduced dose group (n=41) was 100%.CONCLUSIONCT dose reduction technique during image-guided cryoablation treatment of renal tumors can achieve significant radiation dose reduction whilst maintaining sufficient image quality.Renal cell carcinoma is the most common kidney cancer and has a rising incidence (1–4), with obesity and smoking being major risk factors (5–8).Image-guided ablation offers a more minimally invasive option compared with surgery and the current evidence base shows that it is a safe and effective treatment for T1a tumors, with a low rate of complications (9–11). The major advantage of cryoablation over other modalities is the ability to accurately visualize the iceball and therefore zone of ablation on intraprocedural imaging, either with computed tomography (CT) or magnetic resonance imaging (MRI) (12, 13). However, renal cryoablation involves the placement of more ablation probes and can have almost three times the radiation exposure compared with CT-guided radiofrequency ablation procedures (14).In addition to this substantial radiation dose per cryoablation, estimated to be between 32 and 39.7 mSv, the follow-up CT imaging will also add to the total radiation burden (15, 16). Whilst this level of radiation dose and associated stochastic risk may be a lesser concern in the older patients, greater consideration needs to be given to younger patients (<50 years old) and in patients requiring lifelong follow-up imaging, in particular those with hereditary diseases such as Von Hippel-Lindau syndrome (15). To our knowledge, the potential for reducing radiation dose for cryoablation patients.The principle aim of this study was to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in CT-guided percutaneous cryoablation. 相似文献
103.
104.
105.
Non‐melanoma skin cancer frequently results from chronic exposure to ultraviolet (UV) irradiation. UV‐induced DNA damage activates cell cycle arrest checkpoints through degradation of the cyclin‐dependent kinase activators, the cell division cycle 25 (CDC25) phosphatases. We previously reported increased CDC25A in nonmelanoma skin cancer, but CDC25B and CDC25C had not been previously examined. Consequently, we hypothesized that increased expression of CDC25B and CDC25C increases tumor cell proliferation and skin tumor growth. We found that CDC25B and CDC25C were increased in mouse and human skin cancers. CDC25B was primarily cytoplasmic in skin and skin tumors and was significantly increased in the squamous cell carcinoma (SCC), while CDC25C was mostly nuclear in the skin, with an increased cytoplasmic signal in the premalignant and malignant tumors. Surprisingly, forced expression of CDC25B or CDC25C in cultured SCC cells did not affect proliferation, but instead suppressed apoptosis, while CDC25C silencing increased apoptosis without impacting proliferation. Targeting CDC25C to the nucleus via mutation of its nuclear export sequence, however, increased proliferation in SCC cells. Overexpression of CDC25C in the nuclear compartment did not hinder the ability of CDC25C to suppress apoptosis, neither did mutation of sites necessary for its interaction with 14‐3‐3 proteins. Analysis of apoptotic signaling pathways revealed that CDC25C increased activating phosphorylation of Akt on Ser473, increased inhibitory phosphorylation of proapoptotic BAD on Ser136, and increased the survival protein Survivin. Silencing of CDC25C significantly reduced Survivin levels. Taken together, these data suggest that increased expression of CDC25B or CDC25C are mechanisms by which skin cancers evade apoptotic cell death. 相似文献
106.
107.
108.
Toshiro Hara Rony Chanoch-Myers Nathan D. Mathewson Chad Myskiw Lyla Atta Lillian Bussema Stephen W. Eichhorn Alissa C. Greenwald Gabriela S. Kinker Christopher Rodman L. Nicolas Gonzalez Castro Hiroaki Wakimoto Orit Rozenblatt-Rosen Xiaowei Zhuang Jean Fan Tony Hunter Inder M. Verma Kai W. Wucherpfennig Itay Tirosh 《Cancer cell》2021,39(6):779-792.e11
- Download : Download high-res image (228KB)
- Download : Download full-size image
109.
110.